Medical research

Predicting superbugs' countermoves to new drugs

With drug-resistant bacteria on the rise, even common infections that were easily controlled for decades—such as pneumonia or urinary tract infections—are proving trickier to treat with standard antibiotics.

Medications

FDA OKs Cubist antibiotic for serious infections

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Medications

Orbactiv approved for drug-resistant skin infections

(HealthDay)—The antibacterial drug Orbactiv (oritavancin) has been approved by the U.S. Food and Drug Administration to treat drug-resistant skin infections in adults, the agency said in a news release.

Medications

Sivextro approved for adult skin infections

(HealthDay)—The antibiotic Sivextro (tedizolid phosphate) has been approved by the U.S. Food and Drug Administration to treat adults with skin infections.

Diseases, Conditions, Syndromes

Fighting a global war against super-bugs

It reads like the plot of Hollywood's next survival horror film, but it couldn't be more real. A first-of-its-kind report by the World Health Organization details the worldwide spread of drug-resistant super-bugs.

Diseases, Conditions, Syndromes

Signs of success in delaying onset of drug-resistant gonorrhoea in UK

Gonorrhoea threatens to become resistant to all of the antibiotics used to treat it. Today, Professor Cathy Ison will explain that campaigns in the UK to raise awareness of drug resistance among healthcare professionals, ...

page 14 from 21